The new gold (III) complexes were cytotoxic in cisplatin-resistant ovarian carcinoma cells as well as in p53-defective cancer cells of different tumor types, and compound 1 was shown to be less cytotoxic in non-cancer human mesenchymal stromal cells than in cancer cells [24]. The gene discussed is TP53; the disease is cancer.